We are live on ! Find out more
SCPS

Scopus BioPharma Inc. Common Stock
SCPS

Delisted

SCPS was delisted on the 16th of December, 2022.

Back to rankings

28 hedge funds and large institutions have $4.87M invested in Scopus BioPharma Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,200% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 2

662% more capital invested

Capital invested by funds: $639K → $4.87M (+$4.23M)

600% more funds holding

Funds holding: 4 → 28 (+24)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
28
Holders Change
+24
Holders Change %
+600%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
26
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$1.13M
2
Millennium Management
Millennium Management
New York
+$963K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$546K
4
Northern Trust
Northern Trust
Illinois
+$498K
5
BCM
Bridgeway Capital Management
Texas
+$492K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$242K
2
SSA
Schonfeld Strategic Advisors
New York
-$223K
3
TRCT
Tower Research Capital (TRC)
New York
-$12.3K
4
First Manhattan
First Manhattan
New York
-$1.05K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$915K +$1.13M +108,237 New
Millennium Management
2
Millennium Management
New York
$778K +$963K +92,104 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$440K +$546K +52,159 New
Northern Trust
4
Northern Trust
Illinois
$403K +$498K +47,633 New
BCM
5
Bridgeway Capital Management
Texas
$397K +$492K +47,009 New
Two Sigma Investments
6
Two Sigma Investments
New York
$360K +$446K +42,645 New
State Street
7
State Street
Massachusetts
$344K +$426K +40,754 New
Vanguard Group
8
Vanguard Group
Pennsylvania
$205K +$253K +24,187 New
JP Morgan Chase
9
JP Morgan Chase
New York
$173K +$215K +20,527 New
Two Sigma Advisers
10
Two Sigma Advisers
New York
$165K +$204K +19,500 New
Susquehanna International Group
11
Susquehanna International Group
Pennsylvania
$125K +$155K +14,799 New
Charles Schwab
12
Charles Schwab
California
$100K +$124K +11,810 New
Bank of America
13
Bank of America
North Carolina
$91K +$113K +10,760 New
First Manhattan
14
First Manhattan
New York
$87K -$1.05K -100 -1%
New York State Common Retirement Fund
15
New York State Common Retirement Fund
New York
$74K +$91K +8,705 New
California State Teachers Retirement System (CalSTRS)
16
California State Teachers Retirement System (CalSTRS)
California
$71K +$87.5K +8,365 New
Deutsche Bank
17
Deutsche Bank
Germany
$30K +$36.6K +3,495 New
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
$30K +$37.6K +3,592 New
UBS Group
19
UBS Group
Switzerland
$24K +$29.4K +2,811 New
Wells Fargo
20
Wells Fargo
California
$18K +$22.9K +2,188 New
SO
21
STRS Ohio
Ohio
$10K +$13.6K +1,300 New
Morgan Stanley
22
Morgan Stanley
New York
$8K +$10K +957 New
Legal & General Group
23
Legal & General Group
United Kingdom
$5K +$5.66K +541 New
AIP
24
Ameritas Investment Partners
Nebraska
$4K +$4.71K +450 New
Citigroup
25
Citigroup
New York
$4K +$4.89K +468 New
1
2

SCPS Hedge Fund Activity: Q1 2021 in Review

28 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Scopus BioPharma Inc. Common Stock (SCPS) for Q1 2021, worth a combined $4.87M — up 662% from $639K a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new SCPS positions and 2 closed out — a net gain of 24 holders — while 0 added to existing stakes and 2 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $1.13M. The largest seller was Virtu Financial, exiting entirely with an estimated $242K sold.

  • 28 institutional investors held Scopus BioPharma Inc. Common Stock (SCPS) as of Q1 2021, up from 4 in Q4 2020.
  • Funds reported $4.87M of Scopus BioPharma Inc. Common Stock stock for Q1 2021, up 662% quarter-over-quarter.
  • 26 funds opened new Scopus BioPharma Inc. Common Stock positions in Q1 2021 and 2 closed out, a net change of +24 holders.
  • The largest Scopus BioPharma Inc. Common Stock buyer in Q1 2021 was BlackRock, an estimated $1.13M added.
  • The largest Scopus BioPharma Inc. Common Stock seller in Q1 2021 was Virtu Financial, an estimated $242K sold.

Based on aggregated 13F filings for Q1 2021.